Product
23-Valent Pneumococcal Polysaccharide Vaccine
Aliases
23-Valent Pneumococcal Polysaccharide Vaccine（PPV23）
1 clinical trial
3 indications
Indication
DiphtheriaIndication
TetanusIndication
PertussisClinical trial
A Randomized, Blinded, Controlled Phase I Clinical Trial for Preliminary Evaluation of the Safety and Immunogenicity of Adsorbed Cell-free DPT Vaccine (for People Aged 6 Years and Above)Status: Recruiting, Estimated PCD: 2025-02-28